---

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

FORM 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 29, 2003

 

Date of Filing: July 30, 2003

 

---

 

Seattle Genetics, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware (State or other jurisdiction of incorporation or organization)

0-32405 (Commission File Number)

91-1874389 (I.R.S. Employer Identification No.)

 

21823 30th Drive SE

Bothell, Washington 98021

(Address of principal executive offices, including zip code)

 

(425) 527-4000

(Registrant’s telephone number, including area code)

 

 

---

---

Item 7.

Financial Statements and Exhibits

 

(c) Exhibits

 

 

Item 12.

Results of Operations and Financial Conditions

 

On July 29, 2003, Seattle Genetics, Inc. issued a press release announcing financial results for the quarter ended June 30, 2003. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated into this Form 8-K by reference.

 

The information in this Form 8-K, including the attached Exhibit, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

				SEATTLE GENETICS, INC. (Registrant)
Date: July 30, 2003				By:		/s/    CLAY B. SIEGALL
						Clay B. Siegall President and Chief Executive Officer

 

---

INDEX TO EXHIBITS

 

Exhibit No.		Description
99.1		Press Release of Seattle Genetics, Inc. dated July 29, 2003 (financial results for the second quarter of 2003).